Indeed. The portfolio is very impressive. The indi
Post# of 30028
Posted On: 12/11/2014 11:09:09 AM
Re: Daveludlow #12759
Indeed. The portfolio is very impressive. The indications are massive. The orphan strategy out of the gates is smart. The diversity of products across diagnostics, therapeutics, and discovery with Phenoguard is amazing. If AMBS can now turn on the revenue machine with Lympro then AMBS will have turned a valuable corner.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼